No Recent News for the Company
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
27-Nov-2025 | Source : BSEPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
18-Nov-2025 | Source : BSEPlease find the enclosed intimation of the Company as per the captioned subject.
Intimation About Second Brand Partnership Between Astrazeneca Pharma India Limited (Company) And Sun Pharmaceuticals Industries Limited For Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5 G
17-Nov-2025 | Source : BSEPlease find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1600% dividend, ex-date: 18 Jul 25
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available






